Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003329 · ClinicalTrials.gov registry record
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT00003329 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 4,000 participants.
The verdict
NCT00003329 has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: This clinical trial is studying to see if certain genes may be associated with cancer in patients with cancer of the breast, prostate, lung, or colon and siblings of these patients.
Interventions
- GENETIC gene mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1998-04-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003329
The ClinicalTrials.gov registry entry for NCT00003329 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which gene mapping is the first listed.
NCT00003329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003329 about?
NCT00003329 is a clinical study titled "Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer". RATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer. PURPOSE: This clinical trial is studying to see if certain genes may be associated with cancer in patients with cancer...
What is the current status of trial NCT00003329?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 1998-04-07.
What interventions are being tested in trial NCT00003329?
The interventions under investigation include: gene mapping (GENETIC).
Who is sponsoring clinical trial NCT00003329?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.